Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
66.61
-1.97 (-2.87%)
At close: May 22, 2026, 4:00 PM EDT
67.69
+1.08 (1.62%)
After-hours: May 22, 2026, 7:16 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$883,063
Profits / Employee
-$2,509,492
Market Cap
2.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 2 | 3.28% |
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 249 |
| Celldex Therapeutics | 198 |
| Relay Therapeutics | 193 |
| Immunome | 177 |
| Disc Medicine | 154 |
| Kodiak Sciences | 130 |
NKTR News
- 12 days ago - Nektar price target lowered to $80 from $95 at Wedbush - TheFly
- 15 days ago - Nektar Therapeutics Q1 Earnings Call Highlights - MarketBeat
- 15 days ago - Nektar price target raised to $192 from $105 at Piper Sandler - TheFly
- 16 days ago - Nektar Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 16 days ago - Nektar Therapeutics Earnings release: Q1 2026 - Filings
- 16 days ago - Nektar Therapeutics Quarterly report: Q1 2026 - Filings
- 16 days ago - Nektar reports Q1 adjusted EPS ($1.82), consensus ($1.48) - TheFly
- 16 days ago - Nektar Therapeutics Reports First Quarter 2026 Financial Results - PRNewsWire